Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy
Nikolas T. Martin(University of Ottawa), John C. Bell(University of Ottawa)
Cited by 9
Related Papers
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
|Nature Medicine|2015|167
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
|Breast Cancer Research|2016|84
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
|Frontiers in Immunology|2023|13
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development
|Journal of Biological Chemistry|2023|6
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery
|Journal for ImmunoTherapy of Cancer|2026|1